Literature DB >> 19428368

Suppression of topoisomerase IIalpha expression and function in human cells decreases chromosomal radiosensitivity.

Samantha Y A Terry1, Andrew C Riches, Peter E Bryant.   

Abstract

The mechanism behind chromatid break formation is as yet unclear, although it is known that DNA double-strand breaks (DSBs) are the initiating lesions. Chromatid breaks formed in cells in the G2-phase of the cell-cycle disappear ('rejoin') as a function of time between radiation exposure and cell fixation. However, the kinetics of disappearance of chromatid breaks does not correspond to those of DSB rejoining, leading us to seek alternative models. We have proposed that chromatid breaks could be formed indirectly from DSB and that the mechanism involves topoisomerase IIalpha. In support of this hypothesis we have recently shown that frequencies of radiation-induced chromatid breaks are lower in two variant human promyelocytic leukaemic cell lines with reduced topoisomerase IIalpha expression. Here we report that suppression of topoisomerase IIalpha in human hTERT-RPE1 cells, either by its abrogation using specific siRNA or by inhibition of its catalytic activity with the inhibitor ICRF-193, causes a reduction in frequency of chromatid breaks in radiation-exposed cells. The findings support our hypothesis for the involvement of topoisomerase IIalpha in the formation of radiation-induced chromatid breaks, and could help explain inter-individual variation in human chromosomal radiosensitivity; elevation of which has been linked with cancer susceptibility.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19428368      PMCID: PMC6175043          DOI: 10.1016/j.mrfmmm.2009.01.003

Source DB:  PubMed          Journal:  Mutat Res        ISSN: 0027-5107            Impact factor:   2.433


  51 in total

1.  Increased G2 chromosomal radiosensitivity in cancer patients: the role of cdk1/cyclin-B activity level in the mechanisms involved.

Authors:  G I Terzoudi; T Jung; J Hain; J Vrouvas; K Margaritis; C Donta-Bakoyianni; V Makropoulos; P Angelakis; G E Pantelias
Journal:  Int J Radiat Biol       Date:  2000-05       Impact factor: 2.694

2.  Inhibition of topoisomerase II by antitumor agents bis(2,6-dioxopiperazine) derivatives.

Authors:  K Tanabe; Y Ikegami; R Ishida; T Andoh
Journal:  Cancer Res       Date:  1991-09-15       Impact factor: 12.701

Review 3.  Eukaryotic DNA topoisomerase II beta.

Authors:  C A Austin; K L Marsh
Journal:  Bioessays       Date:  1998-03       Impact factor: 4.345

4.  Topoisomerase II inhibitors affect entry into mitosis and chromosome condensation in BHK cells.

Authors:  H Anderson; M Roberge
Journal:  Cell Growth Differ       Date:  1996-01

5.  Identification of differentially expressed genes in human prostate cancer using subtraction and microarray.

Authors:  J Xu; J A Stolk; X Zhang; S J Silva; R L Houghton; M Matsumura; T S Vedvick; K B Leslie; R Badaro; S G Reed
Journal:  Cancer Res       Date:  2000-03-15       Impact factor: 12.701

6.  Activation of topoisomerase II-mediated excision of chromosomal DNA loops during oxidative stress.

Authors:  T K Li; A Y Chen; C Yu; Y Mao; H Wang; L F Liu
Journal:  Genes Dev       Date:  1999-06-15       Impact factor: 11.361

7.  Localisation of DNA topoisomerase IIalpha in mouse erythroleukemia cells.

Authors:  E C Ivanova; R M Donev; L P Djondjurov
Journal:  Mol Cells       Date:  1999-06-30       Impact factor: 5.034

8.  DNA topoisomerase II is required for condensation and separation of mitotic chromosomes in S. pombe.

Authors:  T Uemura; H Ohkura; Y Adachi; K Morino; K Shiozaki; M Yanagida
Journal:  Cell       Date:  1987-09-11       Impact factor: 41.582

9.  Increased chromosomal radiosensitivity in breast cancer patients: a comparison of two assays.

Authors:  D Scott; J B Barber; A R Spreadborough; W Burrill; S A Roberts
Journal:  Int J Radiat Biol       Date:  1999-01       Impact factor: 2.694

10.  Sensitivity to radiation-induced chromosome damage may be a marker of genetic predisposition in young head and neck cancer patients.

Authors:  R Papworth; N Slevin; S A Roberts; D Scott
Journal:  Br J Cancer       Date:  2001-03-23       Impact factor: 7.640

View more
  7 in total

1.  Mechanisms of the formation of radiation-induced chromosomal aberrations.

Authors:  Peter E Bryant; Andrew C Riches; Samantha Y A Terry
Journal:  Mutat Res       Date:  2010-03-27       Impact factor: 2.433

2.  Role of Topoisomerase IIβ in DNA Damage Response following IR and Etoposide.

Authors:  Nicola J Sunter; Ian G Cowell; Elaine Willmore; Gary P Watters; Caroline A Austin
Journal:  J Nucleic Acids       Date:  2010-08-19

3.  A bioinformatics filtering strategy for identifying radiation response biomarker candidates.

Authors:  Jung Hun Oh; Harry P Wong; Xiaowei Wang; Joseph O Deasy
Journal:  PLoS One       Date:  2012-06-29       Impact factor: 3.240

4.  Prognostic effect of class III β-tubulin and Topoisomerase-II in patients with advanced thymic carcinoma who received combination chemotherapy, including taxanes or topoisomerase-II inhibitors.

Authors:  Yosuke Miura; Kyoichi Kaira; Reiko Sakurai; Hisao Imai; Yoshio Tomizawa; Noriaki Sunaga; Koichi Minato; Takeshi Hisada; Tetsunari Oyama; Masanobu Yamada
Journal:  Oncol Lett       Date:  2017-06-19       Impact factor: 2.967

5.  MicroRNA Profiling in Oesophageal Adenocarcinoma Cell Lines and Patient Serum Samples Reveals a Role for miR-451a in Radiation Resistance.

Authors:  Frederike Butz; Ann-Kathrin Eichelmann; George C Mayne; Tingting Wang; Isabell Bastian; Karen Chiam; Shashikanth Marri; Pamela J Sykes; Bas P Wijnhoven; Eelke Toxopeus; Michael Z Michael; Christos S Karapetis; Richard Hummel; David I Watson; Damian J Hussey
Journal:  Int J Mol Sci       Date:  2020-11-24       Impact factor: 5.923

6.  Repair of DNA strand breaks in a minichromosome in vivo: kinetics, modeling, and effects of inhibitors.

Authors:  Slawomir Kumala; Krzysztof Fujarewicz; Dheekollu Jayaraju; Joanna Rzeszowska-Wolny; Ronald Hancock
Journal:  PLoS One       Date:  2013-01-30       Impact factor: 3.240

7.  Requirement for Parp-1 and DNA ligases 1 or 3 but not of Xrcc1 in chromosomal translocation formation by backup end joining.

Authors:  Aashish Soni; Maria Siemann; Martha Grabos; Tamara Murmann; Gabriel E Pantelias; George Iliakis
Journal:  Nucleic Acids Res       Date:  2014-04-19       Impact factor: 16.971

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.